論文

国際誌
2021年4月30日

New inducible mast cell-deficient mouse model (Mcpt5/Cma1DTR).

Biochemical and biophysical research communications
  • Hayato Sasaki
  • Madoka Imanishi
  • Daisuke Fujikura
  • Makoto Sugiyama
  • Kyosuke Tanimoto
  • Yohei Mochiji
  • Yuki Takahashi
  • Koki Hiura
  • Masaki Watanabe
  • Takashige Kashimoto
  • Kenta Nakano
  • Tadashi Okamura
  • Nobuya Sasaki
  • 全て表示

551
開始ページ
127
終了ページ
132
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.bbrc.2021.03.025

Mast cell-deficient mice are helpful for understanding the roles of mast cells in vivo. To date, a dozen mouse models for mast cell deficiency have been reported. However, mice with a specific depletion of all populations of mast cells have not been reported. We generated knock-in mice, termed Mcpt5/Cma1DTR mice, expressing human diphtheria toxin A (DT) receptor under the endogenous promoter of Mcpt5 (also known as Cma1), which encodes mouse mast cell protease-5. Flow cytometry and histological analysis showed that intraperitoneal injection of DT induced almost complete depletion of mast cells in heterozygote Mcpt5/Cma1DTR/+ mice. The deletion rates of mast cells in peritoneal cavity, mesentery, abdominal skin, ear skin, and glandular stomach were 99.9%, 100%, 98.7%, 97.7%, and 100%, respectively. Passive cutaneous anaphylaxis reaction also revealed mast cell deficiency in ear skin after DT treatment. Other than mast cells, a small percentage of marginal zone B cells in Mcpt5/Cma1DTR/+ mice were killed by DT treatment. In conclusion, the Mcpt5/Cma1DTR/+ mouse model is valuable for achieving conditional depletion of all populations of mast cells without inducing a marked reduction in other cells.

リンク情報
DOI
https://doi.org/10.1016/j.bbrc.2021.03.025
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33725574
ID情報
  • DOI : 10.1016/j.bbrc.2021.03.025
  • PubMed ID : 33725574

エクスポート
BibTeX RIS